Related Experiment Video
Updated: Jan 28, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Environmental Pollutants and Protein Destabilization in Lung Cancer: Anticancer Drug Strategies for Structural
Reza Rasoolzadeh1, Homa Faraji2,3, Leonardo Baptista4
1Department of Inorganic Chemistry, Institute of Chemistry, Fluminense Federal University, Niterói, Rio de Janeiro 24020-141, Brazil.
Environmental pollutants like aminoantipyrine (AAP) destabilize lung cancer biomarkers pro-gastrin-releasing peptide (Pro-GRP) and superoxide dismutase (SOD). Anticancer drugs Paclitaxel and Sotorasib show potential in stabilizing these proteins against pollutant effects.
Area of Science:
- Computational biophysics
- Environmental toxicology
- Molecular pharmacology
Background:
- Environmental pollutants bisphenol A (BPA) and aminoantipyrine (AAP) are linked to lung cancer progression.
- These pollutants can alter protein structures, potentially affecting anticancer drug efficacy.
- Pro-gastrin-releasing peptide (Pro-GRP) and superoxide dismutase (SOD) are key lung cancer biomarkers impacted by pollutants.
Purpose of the Study:
- To investigate the molecular mechanisms of BPA and AAP on Pro-GRP and SOD structural dynamics.
- To assess the stabilizing effects of Paclitaxel and Sotorasib against pollutant-induced protein instability.
- To explore the interplay between environmental pollutants, anticancer drugs, and protein targets in lung cancer.
Main Methods:
- Molecular dynamics (MD) simulations
- Molecular docking
- Binding free energy calculations (MM/PBSA)
- Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF) analyses
Main Results:
- Aminoantipyrine (AAP) significantly destabilized both Pro-GRP and SOD structures.
- Bisphenol A (BPA) showed a milder destabilizing effect compared to AAP.
- Paclitaxel and Sotorasib demonstrated protein stabilization by reducing fluctuations and preserving native conformations.
- Anticancer agents were found to modulate pollutant binding at critical residues, potentially mitigating destabilization.
Conclusions:
- Environmental pollutants can disrupt the structure and function of crucial lung cancer biomarkers.
- Anticancer drugs Paclitaxel and Sotorasib may counteract pollutant-induced protein destabilization.
- Computational findings highlight the potential influence of environmental exposures on drug-protein interactions in lung cancer therapy.
- Experimental validation is required to confirm the biological and clinical relevance of these computational predictions.
Related Concept Videos
Drugs that Destabilize Microtubules
Stability of structures
RNA Stability
Drug Product Stability
Drugs that Stabilize Microtubules
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...

